Jazz Pharma (JAZZ) Announces that Lonza has Terminated Their Sodium Oxybate Supply Agreement
Tweet Send to a Friend
On March 22, 2010, Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ) received written notice from Lonza Inc. of its intent to terminate ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE